相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。DNA vaccination with T-cell epitopes encoded within Ab molecules induces high-avidity anti-tumor CD8+ T cells
Victoria A. Pudney et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2010)
Bortezomib treatment and regulatory T-cell depletion enhance the antitumor effects of adoptively infused NK cells
Andreas Lundqvist et al.
BLOOD (2009)
Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired
Mojgan Ahmadzadeh et al.
BLOOD (2009)
Functional implications of T cell receptor diversity
Stephen J. Turner et al.
CURRENT OPINION IN IMMUNOLOGY (2009)
Adoptive cell therapy for the treatment of patients with metastatic melanoma
Steven A. Rosenberg et al.
CURRENT OPINION IN IMMUNOLOGY (2009)
Aflibercept (AVE0005): an alternative strategy for inhibiting tumour angiogenesis by vascular endothelial growth factors
Quincy Siu-Chung Chu
EXPERT OPINION ON BIOLOGICAL THERAPY (2009)
Genetic heterologous prime-boost vaccination strategies for improved systemic and mucosal immunity
Charani Ranasinghe et al.
EXPERT REVIEW OF VACCINES (2009)
High-avidity Autoreactive CD4+ T Cells Induce Host CTL, Overcome Tregs and Mediate Tumor Destruction
Andrew G. Brandmaier et al.
JOURNAL OF IMMUNOTHERAPY (2009)
Antibodies designed as effective cancer vaccines
R. L. Metheringham et al.
MABS (2009)
Depletion of human regulatory T cells specifically enhances antigen-specific immune responses to cancer vaccines
Michael A. Morse et al.
BLOOD (2008)
Molecular mechanisms of MHC class I abnormalities and APM components in human tumors
Barbara Seliger
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
Functions of anti-MAGE T-cells induced in melanoma patients under different vaccination modalities
Thierry Connerotte et al.
CANCER RESEARCH (2008)
Human leukocyte antigen class I, MHC class I chain-related molecule A, and CD8+/regulatory T-cell ratio:: Which variable determines survival of cervical cancer patients?
Ekaterina S. Jordanova et al.
CLINICAL CANCER RESEARCH (2008)
Arginine regulation by myeloid derived suppressor cells and tolerance in cancer: mechanisms and therapeutic perspectives
Paulo C. Rodriguez et al.
IMMUNOLOGICAL REVIEWS (2008)
Are dendritic cells central to regulatory T cell function?
Caroline Coquerelle et al.
IMMUNOLOGY LETTERS (2008)
Tumour-mediated disruption of dendritic cell function: Inhibiting the MEK1/2-p44/42 axis restores IL-12 production and Th1-generation
Andrew Mark Jackson et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Cutting edize: Dendritic cells prime a high avidity CTL response independent of the level of presented antigen
Charles J. Kroger et al.
JOURNAL OF IMMUNOLOGY (2008)
Expression of ICOS on human melanoma-infiltrating CD4+CD25highFoxp3+ T regulatory cells:: Implications and impact on tumor-mediated immune suppression
Laura Strauss et al.
JOURNAL OF IMMUNOLOGY (2008)
Treatment of metastatic melanoma with autologous CD4+T cells against NY-ESO-1
Naomi N. Hunder et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
NKG2D ligands in tumor immunity
N. Nausch et al.
ONCOGENE (2008)
NK cells and cancer immunosurveillance
I. Waldhauer et al.
ONCOGENE (2008)
Unmodified self antigen triggers human CD8 T cells with stronger tumor reactivity than altered antigen
Daniel E. Speiser et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
CTLA-4 control over Foxp3+ regulatory T cell function
Kajsa Wing et al.
SCIENCE (2008)
How regulatory T cells work
Dario A. A. Vignali et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Circulating tumor antigen-specific regulatory T cells in patients with metastatic melanoma
Luis Vence et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
A mycoplasma peptide elicits heteroclitic CD4 T cell responses against tumor antigen MAGE-A6
Lazar Vujanovic et al.
CLINICAL CANCER RESEARCH (2007)
'Coreceptor tuning': cytokine signals transcriptionally tailor CD8 coreceptor expression to the self-specificity of the TCR
Jung-Hyun Park et al.
NATURE IMMUNOLOGY (2007)
Vaccine therapy for melanoma: Current status and future directions
Alicia M. Terando et al.
VACCINE (2007)
Expansion of human T regulatory type 1 cells in the microenvironment of cyclooxygenase 2 overexpressing head and neck squamous cell carcinoma
Christoph Bergmann et al.
CANCER RESEARCH (2007)
Expansion and characteristics of human T regulatory type 1 cells in co-cultures simulating tumor microenvironment
Christoph Bergmann et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
Role of tumor endothelium in CD4+CD25+ regulatory T cell infiltration of human pancreatic carcinoma
Daniel Nummer et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
Cutting edge:: CD8+ T cell clones possess the potential to differentiate into both high- and low-avidity effector cells
Charles J. Kroger et al.
JOURNAL OF IMMUNOLOGY (2007)
Deletional self-tolerance to a melanocyte/melanoma antigen derived from tyrosinase is mediated by a radio-resistant cell in peripheral and mesenteric lymph nodes
Lisa A. Nichols et al.
JOURNAL OF IMMUNOLOGY (2007)
Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women:: an interim analysis of a phase III double-blind, randomised controlled trial
Jorma Paavonen et al.
LANCET (2007)
The autoimmune regulator directly controls the expression of genes critical for thymic epithelial function
Qing-Guo Ruan et al.
JOURNAL OF IMMUNOLOGY (2007)
Cytokines and T-cell homeostasis
Onur Boyman et al.
CURRENT OPINION IN IMMUNOLOGY (2007)
Antigenic targeting of the human mannose receptor induces tumor immunity
Li-Zhen He et al.
JOURNAL OF IMMUNOLOGY (2007)
DC-based cancer vaccines
Eli Gilboa
JOURNAL OF CLINICAL INVESTIGATION (2007)
Tumor evasion of the immune system by converting CD4+ CD25- T cells into CD4+ CD25+ T regulatory cells:: Role of tumor-derived TGF-β
Victoria C. Liu et al.
JOURNAL OF IMMUNOLOGY (2007)
Targeting HER-2/neu in early breast cancer development using dendritic cells with staged interleukin-12 burst secretion
Brian J. Czerniecki et al.
CANCER RESEARCH (2007)
Inhibition of indoleamine 2,3-dioxygenase in dendritic cells by stereoisomers of 1-methyl-tryptophan correlates with antitumor responses
De-Yan Hou et al.
CANCER RESEARCH (2007)
FDA drug approval summary: Bevacizumab (Avastin (R)) plus carboplatin and paclitaxel as first-line treatment of advanced/metastatic recurrent nonsquamous non-small cell lung cancer
Martin H. Cohen et al.
ONCOLOGIST (2007)
Phosphodiesterase-5 inhibition augments endogenous antitumor immunity by reducing myeloid-derived suppressor cell function
Paolo Serafini et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Alternatively activated dendritic cells preferentially secrete IL-10, expand Foxp3+CD4+ T cells, and induce long-term organ allograft survival in combination with CTLA4-Ig
Yuk Yuen Lan et al.
JOURNAL OF IMMUNOLOGY (2006)
Type, density, and location of immune cells within human colorectal tumors predict clinical outcome
Jerom Galon et al.
SCIENCE (2006)
Placebo-controlled phase III trial of immunologic therapy with sipuleucel-T (APC8015) in patients with metastatic, asymptomatic hormone refractory prostate cancer
Eric J. Small et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Vasoactive intestinal peptide generates human tolerogenic dendritic cells that induce CD4 and CD8 regulatory T cells
E Gonzalez-Rey et al.
BLOOD (2006)
Dacarbazine (DTIC) versus vaccination with autologous peptide-pulsed dendritic cells (DC) in first-line treatment of patients with metastatic melanoma:: a randomized phase III trial of the DC study group of the DeCOG
D Schadendorf et al.
ANNALS OF ONCOLOGY (2006)
Expression of the stress-related MHC class I chain-related protein MICA is an indicator of good prognosis in colorectal cancer patients
NFS Watson et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Immunosurveillance is active in colorectal cancer as downregulation but not complete loss of MHC class I expression correlates with a poor prognosis
NFS Watson et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
The neuropeptide vasoactive intestinal peptide generates tolerogenic dendritic cells
M Delgado et al.
JOURNAL OF IMMUNOLOGY (2005)
Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells
J Dannull et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Fugetaxis: active movement of leukocytes away from a chemokinetic agent
F Vianello et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2005)
IL-21 influences the frequency, phenotype, and affinity of the antigen-specific CD8 T cell response
YQ Li et al.
JOURNAL OF IMMUNOLOGY (2005)
Targeting of antigens to activated dendritic cells in vivo cures metastatic melanoma in mice
K Mahnke et al.
CANCER RESEARCH (2005)
Expression of a natural tumor antigen by thymic epithelial cells impairs the tumor-protective CD4+T-cell repertoire
R Bos et al.
CANCER RESEARCH (2005)
Linked foreign T-cell help activates self-reactive CTL and inhibits tumor growth
L Steinaa et al.
JOURNAL OF IMMUNOLOGY (2005)
Specific antitumor immune response induced by a novel DNA vaccine composed of multiple CTL and T helper cell epitopes of prostate cancer associated antigens
HJ Qin et al.
IMMUNOLOGY LETTERS (2005)
Recruitment of latent pools of high-avidity CD8+ T cells to the antitumor immune response
AM Ercolini et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Multiple costimulatory modalities enhance CTL avidity
JW Hodge et al.
JOURNAL OF IMMUNOLOGY (2005)
Overcoming the immortality of tumour cells by telomere and telomerase based cancer therapeutics - current status and future prospects
LR Kelland
EUROPEAN JOURNAL OF CANCER (2005)
Adoptive transfer of tumor-reactive transforming growth factor-β-insensitive CD8+ T cells:: Eradication of autologous mouse prostate cancer
Q Zhang et al.
CANCER RESEARCH (2005)
Recognition of a new ARTC1 peptide ligand uniquely expressed in tumor cells by antigen-specific CD4+ regulatory T cells
HY Wang et al.
JOURNAL OF IMMUNOLOGY (2005)
Differentiation of Tr1 cells by immature dendritic cells requires IL-10 but not CD25+CD4+ Tr cells
MK Levings et al.
BLOOD (2005)
High-avidity CD8(+) T cells - Optimal soldiers in the war against viruses and tumors
MA Alexander-Miller
IMMUNOLOGIC RESEARCH (2005)
Role of dendritic cells in the generation of regulatory T cells
H Groux et al.
SEMINARS IN IMMUNOLOGY (2004)
Mannose receptor targeting of tumor antigen pmel17 to human dendritic cells directs anti-melanoma T cell responses via multiple HLA molecules
V Ramakrishna et al.
JOURNAL OF IMMUNOLOGY (2004)
Improved immunogenicity of a tuberculosis DNA vaccine encoding ESAT6 by DNA priming and protein boosting
QM Wang et al.
VACCINE (2004)
Cancer immunotherapy: moving beyond current vaccines
SA Rosenberg et al.
NATURE MEDICINE (2004)
Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival
TJ Curiel et al.
NATURE MEDICINE (2004)
The immunobiology of cancer immunosurveillance and immunoediting
GP Dunn et al.
IMMUNITY (2004)
IL-15/IL-15Rα-mediated avidity maturation of memory CD8+ T cells
S Oh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Antigen presentation by the endothelium: a green light for antigen-specific T cell trafficking?
FM Marelli-Berg et al.
IMMUNOLOGY LETTERS (2004)
Intestinal epithelial antigen induces mucosal CD8 T cell tolerance, activation, and inflammatory response
ZJ Liu et al.
JOURNAL OF IMMUNOLOGY (2004)
Tumor-specific human CD4(+) regulatory T cells and their ligands: Implications for immunotherapy
HY Wang et al.
IMMUNITY (2004)
CD4 T cells are required for CD8 T cell memory generation
C Bourgeois et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2003)
Regulatory T cells and dendritic cells in transplantation tolerance: molecular markers and mechanisms
SP Cobbold et al.
IMMUNOLOGICAL REVIEWS (2003)
Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase
C Uyttenhove et al.
NATURE MEDICINE (2003)
Rapid high efficiency sensitization of CD8+ T cells to tumor antigens by dendritic cells leads to enhanced functional avidity and direct tumor recognition through an IL-12-dependent mechanism
SW Xu et al.
JOURNAL OF IMMUNOLOGY (2003)
Requirement for CD4 T cell help in generating functional CD8 T cell memory
DJ Shedlock et al.
SCIENCE (2003)
Defective CD8 T cell memory following acute infection without CD4 T cell help
JC Sun et al.
SCIENCE (2003)
Anatomical basis of tolerance and immunity to intestinal antigens
AM Mowat
NATURE REVIEWS IMMUNOLOGY (2003)
CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes
EM Janssen et al.
NATURE (2003)
Targeting apoptotic tumor cells to FcγR provides efficient and versatile vaccination against tumors by dendritic cells
K Akiyama et al.
JOURNAL OF IMMUNOLOGY (2003)
Antigen density presented by dendritic cells in vivo differentially affects the number and avidity of primary, memory, and recall CD8+ T cells
TNJ Bullock et al.
JOURNAL OF IMMUNOLOGY (2003)
Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer
L Zhang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Projection of an immunological self shadow within the thymus by the aire protein
MS Anderson et al.
SCIENCE (2002)
Cancer immunoediting: from immunosurveillance to tumor escape
GP Dunn et al.
NATURE IMMUNOLOGY (2002)
Optimal colocalization of TCR and CD8 as a novel mechanism for the control of functional avidity
AG Cawthon et al.
JOURNAL OF IMMUNOLOGY (2002)
Adapting a transforming growth factor β-related tumor protection strategy to enhance antitumor immunity
CM Bollard et al.
BLOOD (2002)
High-affinity T helper epitope induces complementary helper and APC polarization, increased CTL, and protection against viral infection
JD Ahlers et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
CD8β endows CD8 with efficient coreceptor function by coupling T cell receptor/CD3 to raft-associated CD8/p56lck complexes
A Arcaro et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Blockade of the granzyme B/perforin pathway through overexpression of the serine protease inhibitor PI-9/SPI-6 constitutes a mechanism for immune escape by tumors
JP Medema et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo
D Hawiger et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Phenotypic and functional analysis of CD8+ T cells undergoing peripheral deletion in response to cross-presentation of self-antigen
J Hernandez et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Induction and mechanism of action of transforming growth factor-β-secreting Th3 regulatory cells
HL Weiner
IMMUNOLOGICAL REVIEWS (2001)
Interleukin-10 expressed at early tumour sites induces subsequent generation of CD4+ T-regulatory cells and systemic collapse of antitumour immunity
N Seo et al.
IMMUNOLOGY (2001)
IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity
V Shankaran et al.
NATURE (2001)
Essential role of CD8 palmitoylation in CD8 coreceptor function
A Arcaro et al.
JOURNAL OF IMMUNOLOGY (2000)
Identification of NY-ESO-1 peptide analogues capable of improved stimulation of tumor-reactive CTL
JL Chen et al.
JOURNAL OF IMMUNOLOGY (2000)
In vivo induction of a high-avidity, high-frequency cytotoxic T-lymphocyte response is associated with antiviral protective immunity
C Sedlik et al.
JOURNAL OF VIROLOGY (2000)
T cell tolerance based on avidity thresholds rather than complete deletion allows maintenance of maximal repertoire diversity
JK Sandberg et al.
JOURNAL OF IMMUNOLOGY (2000)
Active movement of T cells away from a chemokine
MC Poznansky et al.
NATURE MEDICINE (2000)
The use of HLA A2,1/p53 peptide tetramers to visualize the impact of self tolerance on the TCR repertoire
J Hernández et al.
JOURNAL OF IMMUNOLOGY (2000)
分享论文
